Photo-biomodulation Therapy for Pain Relief After Caesarean Section
CompletedNot applicableNCT05738239
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
Brief summary (from the registry)
C-sections may result in a lot of pain that is distressing to the mother, and can impact bonding with the baby. Although there are medications used to treat strong pain, they are not good to use after C-sections because they can affect the baby. There is a need for a pain management option that can reduce the use of medications. The investigators are testing the effects of a combined light and laser device (photo-biomodulation therapy; PBMT), used on the wound twice daily, with respect to pain right after surgery, and pain that lasts longer than 6 weeks after surgery.
Study details
- Official title
- Application of Photo-biomodulation as Part of Multimodal Analgesia to Improve Pain Relief and Wound Healing for Patients Having Elective Caesarean Section: a Randomized Controlled Trial
- Conditions
- Interventions
- Device: Laser therapy
- Sponsor
- McMaster University
- Start date
- 2023-09-01
- Primary completion
- 2025-06-30
- Sex
- Female
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Canada
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: • Women aged ≥18 years with planned C-Section under spinal anesthesia. Exclusion Criteria: * Not willing * Language barrier or cannot communicate in English. * History of chronic ongoing pain needing daily opioid medications * High risk or twin/multiple pregnancy * C-Section planned under a general anesthetic.
Canadian sites (1)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05738239